Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients

Author:

Denisenko Natalia P.12ORCID,Kachanova Anastasia A.3ORCID,Sychev Ivan V.4ORCID,Shuev Gregory N.3ORCID,Perfilieva Oksana M.3,Mukhamadiev Reis H.3ORCID,Kazakov Ruslan E.3ORCID,Milyutina Olga I.3ORCID,Konenkova Olga V.3ORCID,Ryzhkin Sergey A.3ORCID,Zhmaeva Elena M.3,Kirienko Sergey L.3,Ivashchenko Dmitriy V.12ORCID,Bure Irina V.12ORCID,Ametov Alexander S.3,Poddubnaya Irina V.3ORCID,Mirzaev Karin B.12ORCID,Sychev Dmitry A.3ORCID

Affiliation:

1. Research Laboratory of Neuroendocrine Tumors , Centre for Personalized Medicine , Saint-Petersburg , Russia

2. Research Institute of Molecular and Personalized Medicine , Russian Medical Academy of Continuous Professional Education , Moscow , Russia

3. Russian Medical Academy of Continuous Professional Education , Moscow , Russia

4. Department of Faculty Therapy with courses of Physiotherapy and Exercise Therapy, Medicine Institute , Ogarev Mordovia State University , Saransk , Russia

Abstract

Abstract Objectives Radioactive iodine therapy is considered for patients with certain clinicopathological factors that predict a significant risk of recurrence, distant metastases of thyroid cancer or disease-specific mortality. The aim of the study was to investigate the association between polymorphisms of genes, products of which are involved in the processes of DNA damage response and autophagy, and the adverse reactions of radioiodine therapy in thyroid cancer patients. Methods The study included 181 patients (37 men, 144 women; median age 56 [41; 66.3] years) with histologically confirmed thyroid cancer and a history of thyroidectomy who received radioiodine therapy. NFKB1, ATM, ATG16L2, ATG10, TGFB1, and TNF polymorphisms were determined by allele-specific realtime-PCR. Results The frequency of adverse reactions was the following: gastrointestinal symptoms – 57.9 %, local symptoms – 65.8 %, cerebral symptoms – 46.8 %, fatigue – 54.4 %; signs of sialoadenitis six months after radioiodine therapy – 25.2 %. TT genotype carriers of ATG10 rs1864183 had higher frequency of gastrointestinal symptoms (vs. CC+CT), the CC genotype carriers of ATG10 rs10514231 had significantly more frequent cerebral symptoms (vs. CT+TT), as well as AA genotype carriers of TGFB1 rs1800469 (vs. AG+GG). CC genotype of ATG10 rs10514231 increased the incidence of radioiodine-induced fatigue, whereas GA genotype of the ATM rs11212570 had a protective role against fatigue. TGFB1 rs1800469 was associated with signs of sialoadenitis six months after radioiodine therapy. Conclusions Genetic factors may contribute to the occurrence of adverse reactions of radioiodine therapy in thyroid cancer patients.

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3